Medifocus (CVE:MFS) Sets New 1-Year Low at $0.01

Medifocus Inc. (CVE:MFS) reached a new 52-week low on Thursday . The stock traded as low as C$0.01 and last traded at C$0.01, with a volume of 50000 shares. The stock had previously closed at C$0.01.

The company has a market cap of $1.85 million and a price-to-earnings ratio of -0.56. The company’s fifty day moving average price is C$0.01 and its two-hundred day moving average price is C$0.02.

About Medifocus (CVE:MFS)

Medifocus Inc, a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue.

Featured Story: Dow Jones Industrial Average (DJIA)

Receive News & Ratings for Medifocus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifocus and related companies with MarketBeat.com's FREE daily email newsletter.